SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Breakthrough Company????? Endovasc ENDV
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Angelo who wrote (53)4/30/1999 6:14:00 PM
From: Dr David Summers   of 94
 
Excuse me again NY, but may I ????

1. Prostaglandin E-1 is already approved by FDA for other indications, so the 5-year discovery process is eliminated.
2. We have already completed both test-tube and animal safety and efficacy experiments successfully. That eliminates 2 years.
3. FDA has already discussed the treatment protocol for our first
applicaton on an informal basis
4. We have already run a clinical pilot run at a FDA approved contract manufacture.
5. We will probably apply as both an "orphan drug" indication and on a "compassion need" request which FDA puts review to the top of the list.
6. We have our clinical sites already FDA approved.
7. Our doctors are FDA approved for the speciality.

All of the above has been disclosed both in Press Releases or within our Business Plan which is the equivalent of a prospectus without all the legal " risk disclaimers" required by the SEC to "unsophisticated" (their term...not mine) investors. I trust you fall into the former and not the latter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News